Prospective Longitudinal Effects of Intra-articular Corticosteroid Injection on Synovial Fluid Oxygen
NCT04804449 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2023-01-26
Summary
Inflammatory arthritis such as rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are characterized by synovial inflammation of joints, potentially leading to joint destruction and functional disability. Inflamed joints have lower oxygen levels. Studying how oxygen level within the joint affect inflammation may lead to new treatments for patients with arthritis. Anti-inflammatory corticosteroid injection into the joint is well tolerated and widely used in clinical practice but its effects on oxygen level within joints is unknown. Therefore, patients who require corticosteroid injection into the joint as routine clinical care will have biological samples collected before and after the injection. This will give new information to put into context the biological effects within the joint, and accelerate development of new treatment approaches in the future.
Conditions
Sponsors & Collaborators
-
University of Oxford
lead OTHER
Principal Investigators
-
Shing Law, BM BCh · University of Oxford
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-04
- Primary Completion
- 2023-01-24
- Completion
- 2023-01-24
Countries
- United Kingdom
Study Locations
More Related Trials
-
Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
NCT00432406 ·Status: COMPLETED ·Phase: PHASE4
-
MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT03355482 ·Status: TERMINATED ·Phase: PHASE2
-
Cross-validation of a Predictive Model of Response to Anti-TNF Alpha Based on Oxylipin Response in Rheumatoid Arthritis
NCT06880146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
NCT00001291 ·Status: COMPLETED
-
Corticosteroids and Anti TNF in Methotrexate Inadequate Responder Rheumatoid Arthritis Patient
NCT01724268 ·Status: UNKNOWN ·Phase: PHASE3
-
Biomarker Signature and Musculoskeletal Ultrasound Profile in Rheumatoid Arthritis Patients
NCT02476084 ·Status: COMPLETED
-
Study Evaluating Anxiety and Depression in Patients With Psoriatic Arthritis
NCT00884468 ·Status: COMPLETED
-
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
NCT00134693 ·Status: COMPLETED ·Phase: PHASE2
-
Draining PLN and Synovial Inflammation in RA Knee Joints Pre and Post Anti-TNF or B Cell Depletion Therapy
NCT01083563 ·Status: TERMINATED
-
Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis
NCT00004686 ·Status: COMPLETED ·Phase: PHASE2
-
Prognostic Indicators and Determinants of the 2-5 Year Outcome in a Cohort of Early Synovitis Patients
NCT00001679 ·Status: COMPLETED
-
Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
NCT02132234 ·Status: UNKNOWN ·Phase: PHASE4
-
Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis
NCT03531073 ·Status: COMPLETED
-
Endothelial Function, Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients: The Influence of Antirheumatic Treatment
NCT00902005 ·Status: COMPLETED
-
Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry
NCT01646385 ·Status: COMPLETED
-
Angiogenic Biomarkers in Juvenile Idiopathic Arthritis
NCT05534347 ·Status: RECRUITING
-
Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis
NCT02264301 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Acthar on Synovial Inflammation in Rheumatoid Arthritis
NCT03511625 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study
NCT00522184 ·Status: COMPLETED ·Phase: PHASE3
-
Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis
NCT05479448 ·Status: RECRUITING
-
Ultrasound Scores as Indication of Response to Subcutaneous Abatacept in Subjects With Rheumatoid Arthritis
NCT01299961 ·Status: COMPLETED ·Phase: PHASE3
-
The Role of Cytokines on Growth Hormone Suppression in Premenopausal Women With Rheumatoid Arthritis and the Effect of Treatment With Etanercept
NCT00034060 ·Status: COMPLETED ·Phase: PHASE2
-
The Pathogenesis of Inflammatory Synovitis: A Study of Early Arthritis
NCT00001375 ·Status: COMPLETED
-
The Oxylipin Response as a New PrEdictive Biomarker of Patient Responsiveness to Biotherapy in Rheumatoid Arthritis (OPERA)
NCT05552105 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Subcutaneous Versus Intravenous ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00505089 ·Status: TERMINATED ·Phase: PHASE1/PHASE2